Form 4/A for BCDA BioCardia, Inc.
Accepted 2023-04-07 00:00:00 ET · period of report 2022-05-12 · accession 0001437749-23-009765 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-04-07 | 2022-05-12 | BCDA | Altman Peter | Pres, CEO, Dir | F - Tax | $1.32 | -26.5K | 321.7K | -8% | -$34.9K |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | F | D | 26,458 | $1.32 | 321,685 | D | — | — | (F2) The original Form 4 incorrectly reported that 31,446 shares had been withheld due to a clerical error. The corrected number is reported herein. (F1) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connections with the net settlement of RSUs vested on April 14, 2022, and does not represent a sale by the reporting person. (F3) The original Form 4 incorrectly reported that 316,697 shares were beneficially owned following the reported transaction. The corrected amount is reported herein. |